High-purity peptide and small-molecule compounds for laboratory use, processed through our structured quantum field of the Leela Infinity Bloc Advanced. Documented. Verified. Repeatable.
Lyophilized peptide. Matte-black tamper-evident vial. QR-coded label linking back to the full Certificate of Analysis for that exact lot — purity, mass, residual solvents, endotoxin screen, and the QEF processing window.
Nothing is anonymous. Nothing is approximate.
Every lot is processed inside a Leela Infinity Bloc Advanced — a quantum-energy device measured on the Hawkins Scale at 8,000 and engineered to harmonize fields up to 200 m. Same Bloc geometry, same exposure window, same logged conditions on every batch.
Compounds intake from vetted manufacturers. Purity claim, COA, and chain-of-custody documented before release for processing.
Third-party HPLC purity, mass-spec identity, endotoxin screen. Lot rejected if any check falls below specification.
Each lot is quantum-charged inside a Leela Infinity Bloc Advanced. Plates parallel-aligned, sealed environment, charge logged for the batch record.
Lyophilized into Type 1 borosilicate vials, capped with PTFE-faced butyl stoppers, crimp-sealed under inert atmosphere.
Final visual, weight, and seal QC. COA generated with charge log, lot tagged, label QR linked. Released to controlled storage at 2–8°C or –20°C.
Filter by category, search by name, click any row to see the sequence, indication research, and the most recent release lot. All compounds are research use only.
| Compound ↓ | Category ↓ | Purity ↓ | Mass ↓ | Storage ↓ | Status ↓ |
|---|
Enter the lot number printed on the vial label, or scan the on-pack QR code. The COA comes back with the assay results, the QEF cycle window, and the chain-of-custody for that exact batch.
Try sample lots: QCL-2604-A12, QCL-2603-B07, QCL-2602-C03
Our minimum release spec is 99% HPLC purity. Anything that doesn't clear the bar is rejected — so by definition, every lot you see published meets the same floor. We quote the standard, not the over-performance.
Independent HPLC, mass spec, and endotoxin testing on every lot. Lot rejected if any spec falls short.
Every vial carries a QR-linked COA. Source, intake, processing window, fill, and release are timestamped.
Temperature- and humidity-monitored facility. Cold-chain handling from fill to dispatch with logged excursions.
Fixed-parameter Leela Infinity Bloc Advanced cycle on every batch. Same Bloc, same geometry, same window across runs.
Our protocol is built around the Leela Infinity Bloc Advanced. Independent institutes have studied this Bloc technology across cellular, physiological, and environmental endpoints. Selected findings below — full reports on the IFQTF platform.
Double-blind laboratory study, University of Tulsa. Human cells exposed to Leela Quantum Bloc technology closed cellular gaps 46–100% faster than untreated controls.
Dr. Robert Sheaff · Univ. of TulsaControlled double-blind experiment. Cells exposed to Leela Quantum Tech's field-based technology demonstrated up to 29% higher ATP levels — the cell's primary energy currency.
Dr. Robert Sheaff · Double-blindRandomized, double-blind, placebo-controlled. With the Leela Quantum Bloc present during 5G exposure, muscle tension, respiration rate, and skin temperature aligned with the no-radiation condition.
BION Institute · SloveniaRandomized, single-blinded, sham-controlled dark-field microscopy. After 10-minute Wi-Fi exposure, the Quantum Bloc significantly reduced red-blood-cell clumping and enhanced white-cell motility.
Dr. Beverly Rubik · Live bloodTriple-blind, placebo-controlled. Statistically significant differences in water structure (spectroscopy), conductivity, and pH-buffering after Bloc exposure vs. placebo.
BION Institute · Super Bloc studyLimbic alpha (relaxation) increased over 13-fold; gamma stress activity reduced 77.6%; beta in temporal lobe reduced 82.9%; HRV parameters significantly improved during 5G exposure.
German Foundation for Health Information & PreventionStudies cited reference Leela Quantum Tech® Bloc technology and have not been evaluated by the FDA. Full reports published on the International Association for Quantum Technology & Frequency Medicine (IFQTF) platform. Findings inform our charging protocol; QCL makes no independent therapeutic claim.
Our standard research kit packages four matched-lot vials with a bound certificate booklet and the on-pack authentication code. Designed for laboratory intake, not consumer shelves.
Methodology write-ups, compound overviews, and observations from the QEF program. Updated monthly. No therapeutic claims, no marketing copy — research notes.
Body Protection Compound-157 remains one of the most studied peptides in tissue remodeling research. We summarize current findings on the VEGFR2 pathway and recent in-vitro models.
Read noteAn overview of the Leela Quantum Bloc literature — wound-healing work at the University of Tulsa (Sheaff, double-blind), the BION 5G physiological-stress study, and BESA blood-harmonization data — and how that informed our protocol.
Read noteAfter February's Category 1 reclassification of fourteen previously restricted peptides, we break down what shifts for the research community and what remains unchanged.
Read noteBrowse the full index, request a research account, or contact the lab team about custom-protocol orders.
All compounds offered by Quantum Cell Labs are intended exclusively for laboratory and investigational research. They are not intended for human or animal consumption, and no therapeutic claims are made or implied.
Our charging protocol uses the Leela Infinity Bloc Advanced, a third-party quantum-energy device. Cited research is published by independent institutes and has not been evaluated by the FDA. Findings inform our methodology; they are not endorsements, and QCL makes no independent therapeutic claim.